retatrutide study news 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in Phase 3 Trial New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most retatrutide #elililly #retatrutide #weightloss #obesitycare

Copycat products and inadequate oversight: We already have a troubling market of compounded products, "research" peptides, microdosing plans, longevity packages, and cosmetic weight-loss programs with inadequate medical supervision

Schlachetzki JCM: chronic peripheral inflammation: a possible contributor to neurodegenerative diseases

Maintaining storage temperatures between 36F and 46F (2C to 8C) is essential for preserving the medications stability and potency

Unlike our analysis of the intake after peripheral injections, there was no compensatory drinking in the 2024-h period after drug administration

Nevertheless, the early findings suggest a beneficial trend worth considering in clinical practice

Some online marketplaces now feature dedicated filters for GLP-1-friendly" products, automatically prioritizing items with lean protein and fibre while excluding refined carbohydrates and excess saturated fat